Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection

Autores
Mendizabal, Manuel; Ridruejo, Ezequiel; Piñero, Federico; Anders, Margarita; Padilla, Martín Jesus; Toro, Luis G.; Torre, Aldo; Montes, Pedro; Urzúa, Alvaro; Gonzalez Ballerga, Esteban; Silveyra, María Dolores; Michelato, Douglas; Díaz, Javier; Peralta, Mirta; Pages, Josefina; García, Sandro Ruiz; Gutierrez Lozano, Isabel; Macias, Yuridia; Cocozzella, Daniel; Chavez Tapia, Norberto; Tagle, Martín; Dominguez, Alejandra; Varón, Adriana; Vera Pozo, Emilia; Higuera de la Tijera, Fátima; Bustios, Carla; Conte, Damián; Escajadillo, Nataly; Rubinstein, Fernando Adrian; Tenorio, Laura
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Introduction and Objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to compare the performance of different prognostic models for predicting mortality. Patients: We performed a prospective cohort study including 2211 hospitalized patients with confirmed SARS-CoV-2 infection from April 15, 2020 through October 1, 2020 in 38 Hospitals from 11 Latin American countries. We registered clinical and laboratory parameters of patients with and without cirrhosis. All patients were followed until discharge or death. We evaluated the prognostic performance of different scoring systems to predict mortality in patients with cirrhosis using ROC curves. Results: Overall, 4.6% (CI 3.7–5.6) subjects had cirrhosis (n = 96). Baseline Child-Turcotte-Pugh (CTP) class was assessed: CTP-A (23%), CTP-B (45%) and CTP-C (32%); median MELD-Na score was 19 (IQR 14−25). Mortality was 47% in patients with cirrhosis and 16% in patients without cirrhosis (P < .0001). Cirrhosis was independently associated with death [OR 3.1 (CI 1.9−4.8); P < .0001], adjusted by age, gender, and body mass index >30. The areas under the ROC curves for performance evaluation in predicting 28-days mortality for Chronic Liver Failure Consortium (CLIF-C), North American Consortium for the Study of End-Stage Liver Disease (NACSELD), CTP score and MELD-Na were 0.85, 0.75, 0.69, 0.67; respectively (P < .0001). Conclusions: SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIFC had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.
Fil: Mendizabal, Manuel. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Ridruejo, Ezequiel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Centro de Educación Médica e Investigaciones Clínicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Piñero, Federico. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Anders, Margarita. Hospital Alemán; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Padilla, Martín Jesus. Hospital Nacional Guillermo Almenara Irigoyen; Perú
Fil: Toro, Luis G.. Fundación de Medellín y Rionegro; Colombia
Fil: Torre, Aldo. Instituto Nacional de Ciencias Médicas y Nutrición; México
Fil: Montes, Pedro. Hospital Nacional Daniel A. Carrión; Argentina
Fil: Urzúa, Alvaro. Universidad de Chile; Chile
Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Silveyra, María Dolores. Sanatorio Anchorena; Argentina
Fil: Michelato, Douglas. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; Brasil
Fil: Díaz, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Peralta, Mirta. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina
Fil: Pages, Josefina. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: García, Sandro Ruiz. Hospital de Víctor Lazarte Echegaray; Perú
Fil: Gutierrez Lozano, Isabel. Centro Médico ABC; México
Fil: Macias, Yuridia. IMSS Hospital General Regional No. 1 “Dr. Carlos Mc Gregor Sánchez”; México
Fil: Cocozzella, Daniel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Hospital Italiano de La Plata; Argentina
Fil: Chavez Tapia, Norberto. Medica Sur Clinic & Foundation; México
Fil: Tagle, Martín. Clínica Anglo-Americana; Perú
Fil: Dominguez, Alejandra. Hospital Padre Hurtado; Chile
Fil: Varón, Adriana. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Fundación Cardio Infantil; Colombia
Fil: Vera Pozo, Emilia. Hospital Regional Dr. Teodoro Maldonado Carbo del IESS; Ecuador
Fil: Higuera de la Tijera, Fátima. Hospital General de México “Dr. Eduardo Liceaga”; México
Fil: Bustios, Carla. Fundación Cardio Infantil; Colombia
Fil: Conte, Damián. Hospital Privado de Córdoba; Argentina
Fil: Escajadillo, Nataly. Universidad Austral; Argentina
Fil: Rubinstein, Fernando Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; Brasil
Fil: Tenorio, Laura. Hospital Nacional Edgardo Rebagliati Martins; Perú
Materia
ACUTE-ON-CHRONIC LIVER FAILURE
CIRRHOSIS
CORONAVIRUS
COVID-19
DEATH
PANDEMIC
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/149753

id CONICETDig_47ff853ff4a64bc7d3ced181b495a67d
oai_identifier_str oai:ri.conicet.gov.ar:11336/149753
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infectionMendizabal, ManuelRidruejo, EzequielPiñero, FedericoAnders, MargaritaPadilla, Martín JesusToro, Luis G.Torre, AldoMontes, PedroUrzúa, AlvaroGonzalez Ballerga, EstebanSilveyra, María DoloresMichelato, DouglasDíaz, JavierPeralta, MirtaPages, JosefinaGarcía, Sandro RuizGutierrez Lozano, IsabelMacias, YuridiaCocozzella, DanielChavez Tapia, NorbertoTagle, MartínDominguez, AlejandraVarón, AdrianaVera Pozo, EmiliaHiguera de la Tijera, FátimaBustios, CarlaConte, DamiánEscajadillo, NatalyRubinstein, Fernando AdrianTenorio, LauraACUTE-ON-CHRONIC LIVER FAILURECIRRHOSISCORONAVIRUSCOVID-19DEATHPANDEMIChttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Introduction and Objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to compare the performance of different prognostic models for predicting mortality. Patients: We performed a prospective cohort study including 2211 hospitalized patients with confirmed SARS-CoV-2 infection from April 15, 2020 through October 1, 2020 in 38 Hospitals from 11 Latin American countries. We registered clinical and laboratory parameters of patients with and without cirrhosis. All patients were followed until discharge or death. We evaluated the prognostic performance of different scoring systems to predict mortality in patients with cirrhosis using ROC curves. Results: Overall, 4.6% (CI 3.7–5.6) subjects had cirrhosis (n = 96). Baseline Child-Turcotte-Pugh (CTP) class was assessed: CTP-A (23%), CTP-B (45%) and CTP-C (32%); median MELD-Na score was 19 (IQR 14−25). Mortality was 47% in patients with cirrhosis and 16% in patients without cirrhosis (P < .0001). Cirrhosis was independently associated with death [OR 3.1 (CI 1.9−4.8); P < .0001], adjusted by age, gender, and body mass index >30. The areas under the ROC curves for performance evaluation in predicting 28-days mortality for Chronic Liver Failure Consortium (CLIF-C), North American Consortium for the Study of End-Stage Liver Disease (NACSELD), CTP score and MELD-Na were 0.85, 0.75, 0.69, 0.67; respectively (P < .0001). Conclusions: SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIFC had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.Fil: Mendizabal, Manuel. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; ArgentinaFil: Ridruejo, Ezequiel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Centro de Educación Médica e Investigaciones Clínicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Piñero, Federico. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; ArgentinaFil: Anders, Margarita. Hospital Alemán; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; ArgentinaFil: Padilla, Martín Jesus. Hospital Nacional Guillermo Almenara Irigoyen; PerúFil: Toro, Luis G.. Fundación de Medellín y Rionegro; ColombiaFil: Torre, Aldo. Instituto Nacional de Ciencias Médicas y Nutrición; MéxicoFil: Montes, Pedro. Hospital Nacional Daniel A. Carrión; ArgentinaFil: Urzúa, Alvaro. Universidad de Chile; ChileFil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Silveyra, María Dolores. Sanatorio Anchorena; ArgentinaFil: Michelato, Douglas. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; BrasilFil: Díaz, Javier. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Peralta, Mirta. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; ArgentinaFil: Pages, Josefina. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; ArgentinaFil: García, Sandro Ruiz. Hospital de Víctor Lazarte Echegaray; PerúFil: Gutierrez Lozano, Isabel. Centro Médico ABC; MéxicoFil: Macias, Yuridia. IMSS Hospital General Regional No. 1 “Dr. Carlos Mc Gregor Sánchez”; MéxicoFil: Cocozzella, Daniel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Hospital Italiano de La Plata; ArgentinaFil: Chavez Tapia, Norberto. Medica Sur Clinic & Foundation; MéxicoFil: Tagle, Martín. Clínica Anglo-Americana; PerúFil: Dominguez, Alejandra. Hospital Padre Hurtado; ChileFil: Varón, Adriana. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Fundación Cardio Infantil; ColombiaFil: Vera Pozo, Emilia. Hospital Regional Dr. Teodoro Maldonado Carbo del IESS; EcuadorFil: Higuera de la Tijera, Fátima. Hospital General de México “Dr. Eduardo Liceaga”; MéxicoFil: Bustios, Carla. Fundación Cardio Infantil; ColombiaFil: Conte, Damián. Hospital Privado de Córdoba; ArgentinaFil: Escajadillo, Nataly. Universidad Austral; ArgentinaFil: Rubinstein, Fernando Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; BrasilFil: Tenorio, Laura. Hospital Nacional Edgardo Rebagliati Martins; PerúMexican Association of Hepatology2021-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/149753Mendizabal, Manuel; Ridruejo, Ezequiel; Piñero, Federico; Anders, Margarita; Padilla, Martín Jesus; et al.; Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection; Mexican Association of Hepatology; Annals of Hepatology; 25; 100350; 11-2021; 1-91665-2681CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1665268121000491info:eu-repo/semantics/altIdentifier/doi/10.1016/j.aohep.2021.100350info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:05:53Zoai:ri.conicet.gov.ar:11336/149753instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:05:53.534CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
title Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
spellingShingle Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
Mendizabal, Manuel
ACUTE-ON-CHRONIC LIVER FAILURE
CIRRHOSIS
CORONAVIRUS
COVID-19
DEATH
PANDEMIC
title_short Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
title_full Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
title_fullStr Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
title_full_unstemmed Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
title_sort Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
dc.creator.none.fl_str_mv Mendizabal, Manuel
Ridruejo, Ezequiel
Piñero, Federico
Anders, Margarita
Padilla, Martín Jesus
Toro, Luis G.
Torre, Aldo
Montes, Pedro
Urzúa, Alvaro
Gonzalez Ballerga, Esteban
Silveyra, María Dolores
Michelato, Douglas
Díaz, Javier
Peralta, Mirta
Pages, Josefina
García, Sandro Ruiz
Gutierrez Lozano, Isabel
Macias, Yuridia
Cocozzella, Daniel
Chavez Tapia, Norberto
Tagle, Martín
Dominguez, Alejandra
Varón, Adriana
Vera Pozo, Emilia
Higuera de la Tijera, Fátima
Bustios, Carla
Conte, Damián
Escajadillo, Nataly
Rubinstein, Fernando Adrian
Tenorio, Laura
author Mendizabal, Manuel
author_facet Mendizabal, Manuel
Ridruejo, Ezequiel
Piñero, Federico
Anders, Margarita
Padilla, Martín Jesus
Toro, Luis G.
Torre, Aldo
Montes, Pedro
Urzúa, Alvaro
Gonzalez Ballerga, Esteban
Silveyra, María Dolores
Michelato, Douglas
Díaz, Javier
Peralta, Mirta
Pages, Josefina
García, Sandro Ruiz
Gutierrez Lozano, Isabel
Macias, Yuridia
Cocozzella, Daniel
Chavez Tapia, Norberto
Tagle, Martín
Dominguez, Alejandra
Varón, Adriana
Vera Pozo, Emilia
Higuera de la Tijera, Fátima
Bustios, Carla
Conte, Damián
Escajadillo, Nataly
Rubinstein, Fernando Adrian
Tenorio, Laura
author_role author
author2 Ridruejo, Ezequiel
Piñero, Federico
Anders, Margarita
Padilla, Martín Jesus
Toro, Luis G.
Torre, Aldo
Montes, Pedro
Urzúa, Alvaro
Gonzalez Ballerga, Esteban
Silveyra, María Dolores
Michelato, Douglas
Díaz, Javier
Peralta, Mirta
Pages, Josefina
García, Sandro Ruiz
Gutierrez Lozano, Isabel
Macias, Yuridia
Cocozzella, Daniel
Chavez Tapia, Norberto
Tagle, Martín
Dominguez, Alejandra
Varón, Adriana
Vera Pozo, Emilia
Higuera de la Tijera, Fátima
Bustios, Carla
Conte, Damián
Escajadillo, Nataly
Rubinstein, Fernando Adrian
Tenorio, Laura
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ACUTE-ON-CHRONIC LIVER FAILURE
CIRRHOSIS
CORONAVIRUS
COVID-19
DEATH
PANDEMIC
topic ACUTE-ON-CHRONIC LIVER FAILURE
CIRRHOSIS
CORONAVIRUS
COVID-19
DEATH
PANDEMIC
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Introduction and Objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to compare the performance of different prognostic models for predicting mortality. Patients: We performed a prospective cohort study including 2211 hospitalized patients with confirmed SARS-CoV-2 infection from April 15, 2020 through October 1, 2020 in 38 Hospitals from 11 Latin American countries. We registered clinical and laboratory parameters of patients with and without cirrhosis. All patients were followed until discharge or death. We evaluated the prognostic performance of different scoring systems to predict mortality in patients with cirrhosis using ROC curves. Results: Overall, 4.6% (CI 3.7–5.6) subjects had cirrhosis (n = 96). Baseline Child-Turcotte-Pugh (CTP) class was assessed: CTP-A (23%), CTP-B (45%) and CTP-C (32%); median MELD-Na score was 19 (IQR 14−25). Mortality was 47% in patients with cirrhosis and 16% in patients without cirrhosis (P < .0001). Cirrhosis was independently associated with death [OR 3.1 (CI 1.9−4.8); P < .0001], adjusted by age, gender, and body mass index >30. The areas under the ROC curves for performance evaluation in predicting 28-days mortality for Chronic Liver Failure Consortium (CLIF-C), North American Consortium for the Study of End-Stage Liver Disease (NACSELD), CTP score and MELD-Na were 0.85, 0.75, 0.69, 0.67; respectively (P < .0001). Conclusions: SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIFC had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.
Fil: Mendizabal, Manuel. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Ridruejo, Ezequiel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Centro de Educación Médica e Investigaciones Clínicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Piñero, Federico. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Anders, Margarita. Hospital Alemán; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: Padilla, Martín Jesus. Hospital Nacional Guillermo Almenara Irigoyen; Perú
Fil: Toro, Luis G.. Fundación de Medellín y Rionegro; Colombia
Fil: Torre, Aldo. Instituto Nacional de Ciencias Médicas y Nutrición; México
Fil: Montes, Pedro. Hospital Nacional Daniel A. Carrión; Argentina
Fil: Urzúa, Alvaro. Universidad de Chile; Chile
Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Silveyra, María Dolores. Sanatorio Anchorena; Argentina
Fil: Michelato, Douglas. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; Brasil
Fil: Díaz, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Peralta, Mirta. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina
Fil: Pages, Josefina. Universidad Austral; Argentina. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina
Fil: García, Sandro Ruiz. Hospital de Víctor Lazarte Echegaray; Perú
Fil: Gutierrez Lozano, Isabel. Centro Médico ABC; México
Fil: Macias, Yuridia. IMSS Hospital General Regional No. 1 “Dr. Carlos Mc Gregor Sánchez”; México
Fil: Cocozzella, Daniel. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Hospital Italiano de La Plata; Argentina
Fil: Chavez Tapia, Norberto. Medica Sur Clinic & Foundation; México
Fil: Tagle, Martín. Clínica Anglo-Americana; Perú
Fil: Dominguez, Alejandra. Hospital Padre Hurtado; Chile
Fil: Varón, Adriana. Red Latinoamericana de Concientización y Educación en Investigación del Hígado; Argentina. Fundación Cardio Infantil; Colombia
Fil: Vera Pozo, Emilia. Hospital Regional Dr. Teodoro Maldonado Carbo del IESS; Ecuador
Fil: Higuera de la Tijera, Fátima. Hospital General de México “Dr. Eduardo Liceaga”; México
Fil: Bustios, Carla. Fundación Cardio Infantil; Colombia
Fil: Conte, Damián. Hospital Privado de Córdoba; Argentina
Fil: Escajadillo, Nataly. Universidad Austral; Argentina
Fil: Rubinstein, Fernando Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Hospital Especializado en Enfermedades Infecciosas Instituto Couto Maia; Brasil
Fil: Tenorio, Laura. Hospital Nacional Edgardo Rebagliati Martins; Perú
description Introduction and Objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized patients with cirrhosis and to compare the performance of different prognostic models for predicting mortality. Patients: We performed a prospective cohort study including 2211 hospitalized patients with confirmed SARS-CoV-2 infection from April 15, 2020 through October 1, 2020 in 38 Hospitals from 11 Latin American countries. We registered clinical and laboratory parameters of patients with and without cirrhosis. All patients were followed until discharge or death. We evaluated the prognostic performance of different scoring systems to predict mortality in patients with cirrhosis using ROC curves. Results: Overall, 4.6% (CI 3.7–5.6) subjects had cirrhosis (n = 96). Baseline Child-Turcotte-Pugh (CTP) class was assessed: CTP-A (23%), CTP-B (45%) and CTP-C (32%); median MELD-Na score was 19 (IQR 14−25). Mortality was 47% in patients with cirrhosis and 16% in patients without cirrhosis (P < .0001). Cirrhosis was independently associated with death [OR 3.1 (CI 1.9−4.8); P < .0001], adjusted by age, gender, and body mass index >30. The areas under the ROC curves for performance evaluation in predicting 28-days mortality for Chronic Liver Failure Consortium (CLIF-C), North American Consortium for the Study of End-Stage Liver Disease (NACSELD), CTP score and MELD-Na were 0.85, 0.75, 0.69, 0.67; respectively (P < .0001). Conclusions: SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIFC had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.
publishDate 2021
dc.date.none.fl_str_mv 2021-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/149753
Mendizabal, Manuel; Ridruejo, Ezequiel; Piñero, Federico; Anders, Margarita; Padilla, Martín Jesus; et al.; Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection; Mexican Association of Hepatology; Annals of Hepatology; 25; 100350; 11-2021; 1-9
1665-2681
CONICET Digital
CONICET
url http://hdl.handle.net/11336/149753
identifier_str_mv Mendizabal, Manuel; Ridruejo, Ezequiel; Piñero, Federico; Anders, Margarita; Padilla, Martín Jesus; et al.; Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection; Mexican Association of Hepatology; Annals of Hepatology; 25; 100350; 11-2021; 1-9
1665-2681
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1665268121000491
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.aohep.2021.100350
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Mexican Association of Hepatology
publisher.none.fl_str_mv Mexican Association of Hepatology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613900588285952
score 13.070432